0001179110-20-009219.txt : 20200821
0001179110-20-009219.hdr.sgml : 20200821
20200821161223
ACCESSION NUMBER: 0001179110-20-009219
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200820
FILED AS OF DATE: 20200821
DATE AS OF CHANGE: 20200821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collins Cynthia
CENTRAL INDEX KEY: 0001405692
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37687
FILM NUMBER: 201123531
MAIL ADDRESS:
STREET 1: 65 WEST WATKINS MILL ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Editas Medicine, Inc.
CENTRAL INDEX KEY: 0001650664
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464097528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-401-9000
MAIL ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
edgar.xml
FORM 4 -
X0306
4
2020-08-20
0
0001650664
Editas Medicine, Inc.
EDIT
0001405692
Collins Cynthia
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE
MA
02141
1
1
0
0
CEO
Common Stock
2020-08-20
4
S
0
1976
36.66
D
45022
D
Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 19, 2020. The sale does not represent a discretionary trade by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $36.44 to $36.66. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Cynthia Collins
2020-08-21